EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Direct Oral Anticoagulation Versus Warfarin in Left Ventricular Thrombus: Pooled Analysis of Randomized Controlled Trials

Anders Olof Sahlén, Haowen Jiang iD, Yee How Lau iD, Lucky Cuenza, F Aaysha Cader, Mohammed Al-Omary, Purich Surunchupakorn, Ka Hei Ho, Jonathan Sung, Derek Lee, Satoshi Honda, Jack Tan Wei Chieh und 1 weitere

The Journal of Clinical Pharmacology · 2023-10 · 63 (10) · 1101-1107

DOI: 10.1002/jcph.2267 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Clinical Pharmacology, online erschienen am 24.05.2023. Verfasst von Anders Olof Sahlén und 12 weiteren Autor:innen. Beteiligte Einrichtung: National Heart Centre Singapore, Singapore, Singapore. Hauptthemen laut MEDLINE: Stroke, Thrombosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with impaired left ventricular (LV) function can develop LV thrombus, a potentially life‐threatening condition due to risk of stroke and embolization. Conventional treatment with vitamin K antagonists (VKAs; e.g., warfarin) puts patients at risk of bleeding, and the use of direct oral anticoagulants (DOACs) appears promising, although data are scant. We searched the published English language literature for randomized controlled trials (RCTs) comparing DOACs with VKAs in LV thrombus. End points were failure to resolve, thromboembolic events (stroke, embolism), bleeding, or any adverse event (composite of thromboembolism or bleeding), or all‐cause death. Data were pooled and analyzed in hierarchical Bayesian models. In three eligible RCTs, 141 patients were studied during an average of 4.6 months (53.8 patient‐years; n = 71 assigned to DOAC, n = 70 assigned to VKA). A similar number of patients in each treatment arm demonstrated failure to resolve (DOAC: 14/71 vs. VKA: 15/70) and death events (3/71 vs. 4/70). However, patients on DOACs suffered fewer strokes/thromboembolic events (1/71 vs. 7/70; log odds ratio [OR], −2.02 [95% credible interval (CI 95 ), −4.53 to −0.31]) and fewer bleeding events (2/71 vs. 9/70; log OR, −1.62 [CI 95 , −3.43 to −0.26]), leading to fewer patients on DOACs with any adverse event versus VKAs (3/71 vs. 16/70; log OR, −1.93 [CI 95 , −3.33 to −0.75]). In conclusion, pooled analysis of RCT data favors DOACs over VKAs in patients with LV thrombus in terms of both efficacy and safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StrokeThrombosisHumansWarfarinRandomized Controlled Trials as TopicAnticoagulantsHemorrhageAdministration, Oral

Stichwörter der Autor:innen

LV thrombusdirect oral anticoagulationthromboembolismwarfarin

Substanzen

WarfarinAnticoagulants

Autor:innen und Institutionen

  • National Heart Centre Singapore, Singapore, Singapore.
  • Duke-NUS Medical School, Singapore, Singapore.
  • Karolinska Institutet, Huddinge, Sweden.
  • Lee Kong Chian School of Medicine, Singapore, Singapore.
  • Philippines Heart Center, Quezon City, Philippines.
  • Ibrahim Cardiac Hospital and Research Institute, Dhaka, Bangladesh.

ORCID-Profile: Haowen Jiang, Yee How Lau

Zitieren

APA

Sahlén, A. O., Jiang, H., Lau, Y. H., Cuenza, L., Cader, F. A., Al-Omary, M., Surunchupakorn, P., Ho, K. H., Sung, J., Lee, D., Honda, S., Tan Wei Chieh, J., & Yap, J. (2023). Direct Oral Anticoagulation Versus Warfarin in Left Ventricular Thrombus: Pooled Analysis of Randomized Controlled Trials. The Journal of Clinical Pharmacology, 63(10), 1101-1107. https://doi.org/10.1002/jcph.2267

Vancouver

Sahlén AO, Jiang H, Lau YH, Cuenza L, Cader FA, Al-Omary M, et al. Direct Oral Anticoagulation Versus Warfarin in Left Ventricular Thrombus: Pooled Analysis of Randomized Controlled Trials. The Journal of Clinical Pharmacology. 2023;63(10):1101-1107. doi:10.1002/jcph.2267

BibTeX
@article{Sahln2023,
  author = {Sahlén, Anders Olof and Jiang, Haowen and Lau, Yee How and Cuenza, Lucky and Cader, F Aaysha and Al-Omary, Mohammed and Surunchupakorn, Purich and Ho, Ka Hei and Sung, Jonathan and Lee, Derek and Honda, Satoshi and Tan Wei Chieh, Jack and Yap, Jonathan},
  title = {Direct Oral Anticoagulation Versus Warfarin in Left Ventricular Thrombus: Pooled Analysis of Randomized Controlled Trials},
  journal = {The Journal of Clinical Pharmacology},
  year = {2023},
  volume = {63},
  number = {10},
  pages = {1101--1107},
  doi = {10.1002/jcph.2267}
}
Kostenlos starten →